Literature DB >> 31448453

LncRNA HULC promotes lung squamous cell carcinoma by regulating PTPRO via NF-κB.

Yang Xu1, Jingyun Li1, Pingping Wang2, Zhenliang Zhang3, Xuetao Wang1.   

Abstract

Accumulating studies have implicated that long noncoding RNA (lncRNA) plays a vital role in lung cancer. However, little is known of the role of lncRNA highly upregulated in liver cancer (HULC) in the pathogenesis of lung squamous cell carcinoma (LSCC). In this study, we investigated the modifying effects and underlying mechanisms of lncRNA HULC in LSCC. Significantly decreased level of lncRNA HULC was observed in LSCC samples compared with adjacent tissues. Besides, the expression of lncRNA HULC was negatively associated with protein tyrosine phosphatase receptor type O (PTPRO) in LSCC. Moreover, lncRNA HULC could promote the proliferation of LSCC cells by downregulating the expression PTPRO dependent on the phosphorylation and activation of nuclear factor-κB (NF-κB). The present study firstly shows strong evidence supporting a critical role of lncRNA HULC in promoting LSCC by regulating PTPRO/NF-κB signaling pathway, which provides new promising biomarkers for LSCC.
© 2019 Wiley Periodicals, Inc.

Entities:  

Keywords:  long noncoding RNA; lung cancer; nuclear factor-κB; protein tyrosine phosphatase receptor type O

Mesh:

Substances:

Year:  2019        PMID: 31448453     DOI: 10.1002/jcb.29119

Source DB:  PubMed          Journal:  J Cell Biochem        ISSN: 0730-2312            Impact factor:   4.429


  18 in total

1.  Up-regulation of LINC00665 contributes to the progression of glioma and correlates with its MRI characteristics.

Authors:  Wangsheng Chen; Lan Hong; Changlong Hou; Genlin Zong; Jianhua Zhang
Journal:  Am J Transl Res       Date:  2022-05-15       Impact factor: 3.940

2.  LncRNA PITPNA-AS1/miR-223-3p/PTN axis regulates malignant progression and stemness in lung squamous cell carcinoma.

Authors:  Bi-Hao Peng; Yu-Fei Ji; Xiao-Jian Qiu
Journal:  J Clin Lab Anal       Date:  2022-05-19       Impact factor: 3.124

3.  Identification of a glycolysis-related gene signature associated with clinical outcome for patients with lung squamous cell carcinoma.

Authors:  Ziming Xu; Shiwei Zhang; Fulai Nian; Shangyu Xu
Journal:  Cancer Med       Date:  2021-05-15       Impact factor: 4.452

4.  Quantitative Proteomics Analysis Indicates That Upregulation of lncRNA HULC Promotes Pathogenesis of Glioblastoma Cells.

Authors:  Yuchen Hu; Shan Ye; Qian Li; Tiantian Yin; Jing Wu; Jie He
Journal:  Onco Targets Ther       Date:  2020-06-22       Impact factor: 4.147

5.  FOXD3‑AS1/miR‑128‑3p/LIMK1 axis regulates cervical cancer progression.

Authors:  Xiufang Yang; Huilan Du; Wenhui Bian; Qingxue Li; Hairu Sun
Journal:  Oncol Rep       Date:  2021-03-24       Impact factor: 3.906

6.  Identification of a prognostic long noncoding RNA signature in lung squamous cell carcinoma: a population-based study with a mean follow-up of 3.5 years.

Authors:  Rongjiong Zheng; Mengdi Zheng; Mingming Wang; Feijie Lu; Meiling Hu
Journal:  Arch Public Health       Date:  2021-04-28

7.  LncRNA NNT-AS1 promotes lung squamous cell carcinoma progression by regulating the miR-22/FOXM1 axis.

Authors:  Jing Ma; Guanbin Qi; Lei Li
Journal:  Cell Mol Biol Lett       Date:  2020-05-29       Impact factor: 5.787

8.  Long noncoding RNA RHPN1-AS1 promotes colorectal cancer progression via targeting miR-7-5p/OGT axis.

Authors:  Wei Zheng; Hui Li; Hui Zhang; Chao Zhang; Zhonglin Zhu; Hong Liang; Yifeng Zhou
Journal:  Cancer Cell Int       Date:  2020-02-18       Impact factor: 5.722

9.  The Long Noncoding RNA Linc01833 Enhances Lung Adenocarcinoma Progression via MiR-519e-3p/S100A4 Axis.

Authors:  Yuan Zhang; Wenhua Li; Zongxiang Lin; Jingfeng Hu; Jingpu Wang; Yukai Ren; BoChong Wei; Yuxia Fan; Yang Yang
Journal:  Cancer Manag Res       Date:  2020-11-03       Impact factor: 3.989

10.  LINC00511 promotes lung squamous cell carcinoma proliferation and migration via inhibiting miR-150-5p and activating TADA1.

Authors:  Ying Wu; Li Li; Qun Wang; Li Zhang; Can He; Xihua Wang; Hongbing Liu
Journal:  Transl Lung Cancer Res       Date:  2020-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.